Voyager Therapeutics – IPO

Boston – November 19, 2015 – Cooley advised the underwriters on Voyager Therapeutics' $80.5 million initial public offering. Voyager is a clinical-stage gene therapy company focused on developing life-changing treatments for patients suffering from severe diseases of the central nervous system. The company now trades on the NASDAQ Global Select Market under the symbol "VYGR."

Cowen and Company and Piper Jaffray & Co. acted as joint book-running managers for the offering. Wedbush PacGrow and Nomura acted as co-managers.

The Cooley corporate and securities team advising the underwriters included Marc Recht, Richard Segal, Pia Kaur and Wilber Barillas.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 850 lawyers across 12 offices in the United States, China and Europe.